12:00 AM
Nov 18, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Galectin Therapeutics completes private placement

Galectin Therapeutics Inc. (NASDAQ:GALT), Norcross, Ga.
Business: Cancer, Hepatic
Date completed: 11/12/13

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >